About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Mild Drug Offers Hope in Treating Severe Alzheimer's

by VR Sreeraman on July 31, 2007 at 4:40 PM
Font : A-A+

Mild Drug Offers Hope in Treating Severe Alzheimer's

A new study has discovered that a drug initially used to treat mild to moderate Alzheimer's disease improved the memory and global function of people with severe Alzheimer's disease, and was safe and effective.

The six-month study involved 343 people with severe Alzheimer's disease at clinics in the United States, Canada, France, the United Kingdom, and Australia. Half of the group received a daily dose of donepezil; the other half received placebo. Cognitive tests were performed throughout the study.

Advertisement

The study found cognitive function stabilized or improved in 63 percent of people taking donepezil compared to 39 percent of people taking placebo. Compared to the placebo group, those taking donepezil showed improvement in memory, language, attention, and recognizing one's name. The donepezil group also showed less of a decline in social interaction, skills needed to complete a jigsaw puzzle, and arranging sentences compared to the placebo group.

"The effectiveness of donepezil in preserving cognitive and global function in people with severe Alzheimer's disease, as evidenced by this study and others, is encouraging," said study author Sandra Black, MD, Brill Professor of Neurology at Sunnybrook Health Sciences Centre, University of Toronto in Canada, and member of the American Academy of Neurology.
Advertisement

"People who progress to the severe stage of Alzheimer's disease have markedly diminished cognitive and global function, so preserving cognitive function is a worthwhile treatment goal because it may help to keep patients at home longer, something that patients and caregivers often desire and which delays the costs of nursing home care," said Black.

According to Black, the most common side effects reported in this study, diarrhea, insomnia, nausea, infection, and bladder problems, were mild to moderate and consistent with the known side effects of such drugs.

"Our findings provide further evidence that donepezil is safe, effective and benefits cognition and global function in people with severe Alzheimer's disease," she said.

The study is published in the July 31, 2007, issue of Neurology(r), the medical journal of the American Academy of Neurology.

Source: ANI
LIN/B
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
How to Battle Boredom during COVID
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity 

Recommended Reading
Alzheimers Disease
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and ......
Experts Propose New Criteria for Alzheimer's Diagnosis
An international group of experts have proposed new criteria for the diagnosis of Alzheimer's ......
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use